News Article

Drs. Rich Fogel, Doug Apple on ‘chief medical officers to know’ list

Rich Fogel, MD, FACC, FHRS, Executive Vice President and Chief Clinical Officer, Ascension, and Douglas Apple. MD, Chief Clinical Officer, Ascension Michigan, are included in “110 hospital and health system chief medical officers to know” in 2023 by Becker’s Healthcare.

“The executives featured on this list play a crucial role in directing their organizations’ forward momentum while continuing to serve their patients and communities first and foremost,” Becker’s said.

Dr. Fogel was named to the role last year, bringing a breadth of clinical and operational experience along with a passion for providing personalized care to all patients, Becker’s said. During his time as a clinical leader for Ascension, he has championed quality and safety improvements and practices, overseen the design of flexible physician alignment strategies and service lines, and helped develop an Ascension-wide clinical research infrastructure.

Dr. Apple is accountable for clinical performance across 16 acute care and more than 300 ambulatory care practice sites. He leads population health and value-based programs, along with acute care services, medical staff governance, ambulatory care programs, physician hospital organizations, and Ascension Medical Group in Michigan.

 

Recent National News
Ascension names two new members to its Board of Directors
News Articles

Ascension names two new members to its Board of Directors

Ascension today announced the appointments of Kedar S. Mate, MD, and David P. King to its Board of Directors, effective September 16, 2026.
Building a more integrated approach to rehabilitation across Ascension
News Articles

Building a more integrated approach to rehabilitation across Ascension

During National Rehabilitation Awareness Week, Ascension is highlighting its broader strategy to strengthen and connect rehabilitation services across its footprint.
Ascension reports $1.5B of Net Income, 141% growth YoY; Turns Operating Margin positive on core operations and closes AmSurg acquisition in FY26
News Releases

Ascension reports $1.5B of Net Income, 141% growth YoY; Turns Operating Margin positive on core operations and closes AmSurg acquisition in FY26

Ascension today announced strong financial results through the fourth quarter of fiscal year 2026, ending June 30, 2026, reporting net income of positive $1.5 billion.